心泰片治疗胸痹(冠心病、心绞痛)临床研究

Study on Clinical Curative Effect of Xintai Tablets for Chest Pain(Coronary Heart Disease and Angina Pectoris)

心泰片是湖南省中医药研究院中药研究所研究开发的以广枣为主要药材的中药新药,主要用于心血瘀阻及心血瘀阻兼心阴虚证的胸痹病人。对此类证型患者进行了307例的疗效研究,其结果为:治疗胸痹(心绞痛)显效率为56.02%,总有效率为93.48%;心电图显效率34.38%,总有效率65.28%;硝酸甘油停减80%以上者达40.69%,停减50%以上者共87.75%;综合疗效显效率50.49%,总有效率91.86%。

Xintai Tablets,mainly composed of is the National Grade C of Chinese herb medicine newly developed by the Acadamy of TCM of Hunan Province,Institute of Chinese Herb Medicine.The new certification number of the Ministry of health is WEIYAOZHENGZI 1997-Z-055.Its clinical investigation was undertaken during four hospitals(the First Hospital Affiliated to Hunan College of TCM,etc.)in 1995.It suits well to those patients who suf- fered from the chest pain with the heart-blood stasis or heart-blood stasis and defifiency of heart-yin concomitantly.The clinical investigation on 307 cases indicated that the obvious ef- fective rate for the chest pain with angina pectoris is 56.02% with 93.48% of overall effec- tive rate,for the electrocardiogram is 34.38% with 62.28% of overall effective rate,for over 80% of stopping or reducing nitroglycerin is up to 40.69% ,over 50% of stopping or reducing nitroglycerin is up to 87.75%.The obvious effective rate of synthesis curative effect is 50.49% with 91.86% of overall effective rate.